-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Neotripterifordin
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/149249-32-12d.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 149249-32-1 |
| Description | Neotripterifordinl is extracted from the roots of Tripterygium wilfordii. It displays potent anti-HIV replication activity with an EC50 value of 25 nM in H9 lymphocyte cells. |
Product Information
| Synonyms | Neotripterifordin;149249-32-1;(1R,2R,5S,6R,8S,11R,12R)-6-hydroxy-6,12-dimethyl-14-oxapentacyclo[10.3.3.15,8.01,11.02,8]nonadecan-15-one; |
| IUPAC Name | (1R,2R,5S,6R,8S,11R,12R)-6-hydroxy-6,12-dimethyl-14-oxapentacyclo[10.3.3.15,8.01,11.02,8]nonadecan-15-one |
| Molecular Weight | 318.45 |
| Molecular Formula | C20H30O3 |
| Canonical SMILES | O=C(OC1)[C@]([C@@](CC2)([H])[C@@]31C)(CCC3)[C@@]4([H])[C@]2(C[C@@](O)5C)C[C@H]5CC4 |
| InChI | InChI=1S/C20H30O3/c1-17-7-3-8-20(16(21)23-12-17)14(17)6-9-19-10-13(4-5-15(19)20)18(2,22)11-19/h13-15,22H,3-12H2,1-2H3/t13-,14+,15+,17-,18+,19-,20-/m0/s1 |
| InChIKey | WAZWEQYFSTXTHA-CXICKFFISA-N |
| Boiling Point | 485.1±28.0°C at 760 mmHg |
| Purity | 98.5% |
| Density | 1.2±0.1 g/cm3 |
| Solubility | Soluble in Acetone, Chloroform, Dichloromethane, DMSO, Ethyl Acetate |
| Appearance | Powder |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
